Source: Veru, Inc. From: globenewswire.com Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that it has initiated and enrolled the first patient in a clinical trial of its proprietary, next generation prostate cancer drug, VERU-111. The open-label Phase 1b/2 clinical trial for VERU-111, a novel oral drug, will be evaluated in men with metastatic refractory prostate …
Living With Cancer: Some Men With Prostate Cancer Opt Out of Surgery
From: newsroom.cedars-sinai.org Dale White was diagnosed with prostate cancer six years ago. His doctor told him that surviving prostate cancer depended on one treatment option: surgery. ”I was shocked. I thought that was too radical,” said White, 69. ”So I searched for other options and ended up at Cedars-Sinai, where Dr. Posadas told me I was a good candidate for active …
Hormone Therapy Can Make Prostate Cancer Worse, Study Finds
Scientists at Cedars-Sinai have discovered how prostate cancer can sometimes withstand and outwit a standard hormone therapy, causing the cancer to spread. Their findings also point to a simple blood test that may help doctors predict when this type of hormone therapy resistance will occur. Prostate cancer is the second-leading cause of cancer death in men, behind lung cancer, killing …
What Is Active Surveillance for Breast Cancer?
By Elaine K. Howley From: health.usnews.com Cancer cells don’t all grow and spread at the same speed. Some, as with prostate cancer, can be slow-growing, so oncologists have taken the approach at times that it’s safe to do so-called watchful waiting, or active surveillance, to see if the cancer starts to cause problems before they undertake invasive treatments. Active surveillance …
New Blood Test May Detect Multiple Types of Cancer at Earlier Stages
From: healthline.com Screening methods for certain types of cancer, particularly breast cancer and prostate cancer, can lead to early diagnosis. However, there’s no catchall test to screen for every one of the more than 100 types of cancer that exist. Researchers at GRAIL, a Silicon Valley healthcare company, are working on a DNA test based off a simple blood draw that can …
This ‘metastasis-blocking’ compound may stop the spread of cancer
By: Catharine Paddock PhD From: medicalnewstoday.com Using a new approach, scientists have located a compound that stops the spread of breast, pancreatic, and prostate cancers in mice. The compound — which they call metarrestin — destroys a unique structure inside the nucleus of cancer cells that can spread and form new tumors. A paper on the work — in which researchers from the National Institutes …
Blood test could detect people’s breast cancer risk at birth and save millions of lives, research claims
By: Sun Reporter From: thesun.co.uk Doctor Anna Rose’s revolutionary research could mean that previously overlooked information could now be used to actually identify cancers at an earlier stage. A SIMPLE blood test costing a few pounds could detect the risk of cancer at birth. Researcher Dr Anna Rose, 31, of the John Radcliffe Hospital in Oxford, found a test on …
OHSU kicks off initiative to personalize clinical trials for cancer
By: Tom Sullivan From: healthcareitnews.com Oregon Health & Science University on Thursday announced a new research project to create personalized clinical trials for cancers, including breast, pancreatic and prostate. With the new initiative, OHSU joins a growing number of academic medical centers and hospitals undertaking precision medicine initiatives focused specifically on cancer, including Swedish Cancer Institute and Intermountain Healthcare in …
The Prostate Cancer Foundation, in Collaboration With World’s Leading Researchers, Publish Standard Setting Comprehensive Patient Guide
Source: Prostate Cancer Foundation From: PR Newswire Guide Offers Recommendations on Newest Life-Extending Treatments for Men with Metastatic Prostate Cancer and their Families The Prostate Cancer Foundation, in honor of Prostate Cancer Awareness Month this September, today released the Prostate Cancer Patient Guide, a new, comprehensive health guide for prostate cancer patients, of whom there are estimated to be three …
The Messenger Also Matters: Value-Based Payment Can Support Outreach To Vulnerable Populations
By: Ruth C. Browne, Marilyn Fraser, Judith Killen, and Laura Tollen From: healthaffairs.org With the proliferation of value-based payment initiatives and implementation of the Affordable Care Act’s (ACA’s) coverage expansions, states have had many opportunities in recent years to improve the health of vulnerable populations through health promotion, prevention, and care coordination. We believe value-based payment models can and must …